Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]

Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] was reported 1940 times

Drugs of the Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DEPRESSION RATING SCALE SCORE INCREASED 1 0.1667
1 PHOTOSENSITIVE SEIZURE 1 0.1250
2 PERINATAL DEPRESSION 48 0.1064
3 INFANT SEDATION 3 0.0909
4 CHANGE IN SEIZURE PRESENTATION 43 0.0665
5 LABELLED DRUG-ALCOHOL INTERACTION ISSUE 1 0.0526
6 BRIEF PSYCHOTIC DISORDER, WITH POSTPARTUM ONSET 4 0.0513
7 SOMNOLENCE NEONATAL 10 0.0513
8 POSTPARTUM ANXIETY 1 0.0500
9 BREAST MILK DISCOLOURATION 1 0.0417
10 GASTROSTOMY FAILURE 1 0.0323
11 RASH NEONATAL 1 0.0303
12 GALACTOSTASIS 1 0.0204
13 FOETAL VASCULAR MALPERFUSION 1 0.0196
14 LACTATION INSUFFICIENCY 4 0.0193
15 LACTATION PUERPERAL INCREASED 1 0.0172
16 HANGING 3 0.0152
17 MEDICAL DEVICE BATTERY REPLACEMENT 2 0.0148
18 SCOLIOSIS SURGERY 1 0.0139
19 FEELING DRUNK 91 0.0122
20 TACITURNITY 1 0.0114
21 VERTEBROBASILAR ARTERY DISSECTION 1 0.0114
22 INTRUSIVE THOUGHTS 13 0.0110
23 TIME PERCEPTION ALTERED 4 0.0110
24 SLEEP INERTIA 1 0.0103
25 INFANT IRRITABILITY 1 0.0102
26 SEIZURE CLUSTER 8 0.0097
27 TENOTOMY 1 0.0092
28 COLD FLASH 1 0.0086
29 ILLICIT PRESCRIPTION ATTAINMENT 1 0.0083
30 ACTIVITIES OF DAILY LIVING DECREASED 5 0.0078
31 EXPOSURE VIA BREAST MILK 26 0.0065
32 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 2 0.0065
33 DEVICE DEPENDENCE 1 0.0064
34 LACTATION DISORDER 3 0.0062
35 SEDATION 159 0.0061
36 SWELLING OF NOSE 1 0.0058
37 FOOD REFUSAL 5 0.0057
38 HEMIHYPOAESTHESIA 2 0.0057
39 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 3 0.0056
40 AUTOSCOPY 3 0.0056
41 TRACHEITIS 4 0.0052
42 INCREASED NEED FOR SLEEP 1 0.0043
43 SLOW SPEECH 10 0.0041
44 PULMONARY CONTUSION 1 0.0040
45 VAGUS NERVE DISORDER 1 0.0040
46 BRAIN FOG 60 0.0038
47 AGITATED DEPRESSION 1 0.0035
48 SOMNOLENCE 695 0.0034
49 MORBID THOUGHTS 4 0.0034
50 HYPOAESTHESIA EYE 2 0.0034
51 EAR TUBE INSERTION 1 0.0034
52 VAGAL NERVE STIMULATOR IMPLANTATION 1 0.0033
53 TONGUE SPASM 1 0.0032
54 DREAMY STATE 1 0.0031
55 TONIC CONVULSION 4 0.0028
56 FACIAL DISCOMFORT 2 0.0028
57 BRADYPHRENIA 18 0.0028
58 NON-SMALL CELL LUNG CANCER STAGE IV 1 0.0027
59 INDIFFERENCE 2 0.0027
60 SELF-INJURIOUS IDEATION 11 0.0026
61 CREATINE KINASE INCREASED 2 0.0026
62 CONVULSIVE THRESHOLD LOWERED 1 0.0025
63 EYELID FUNCTION DISORDER 2 0.0025
64 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
65 MUSCLE STRENGTH ABNORMAL 1 0.0024
66 ATONIC SEIZURES 2 0.0023
67 TACHYPHRENIA 8 0.0023
68 HANGOVER 8 0.0023
69 DEPRESSIVE SYMPTOM 8 0.0023
70 DELUSION OF GRANDEUR 1 0.0022
71 MECHANICAL URTICARIA 1 0.0021
72 LACRIMATION DECREASED 1 0.0021
73 TRACHEOSTOMY 3 0.0021
74 APRAXIA 3 0.0020
75 GASTROSTOMY 3 0.0019
76 GRIEF REACTION 1 0.0019
77 SEIZURE 218 0.0019
78 MOTOR DYSFUNCTION 19 0.0019
79 EXECUTIVE DYSFUNCTION 1 0.0018
80 MORNING SICKNESS 1 0.0018
81 THERAPY CHANGE 18 0.0018
82 DISSOCIATION 14 0.0018
83 DYSPHEMIA 8 0.0018
84 BIPOLAR I DISORDER 4 0.0018
85 MUSCLE TWITCHING 41 0.0018
86 PRECOCIOUS PUBERTY 1 0.0018
87 FLASHBACK 1 0.0017
88 FLAT AFFECT 4 0.0017
89 THOUGHT BLOCKING 1 0.0017
90 IRREGULAR BREATHING 1 0.0017
91 UMBILICAL CORD AROUND NECK 1 0.0017
92 BLOOD OESTROGEN INCREASED 1 0.0017
93 AMBLYOPIA 1 0.0017
94 DROP ATTACKS 1 0.0017
95 AGRAPHIA 1 0.0017
96 ARTHRITIS REACTIVE 1 0.0016
97 SLOW RESPONSE TO STIMULI 2 0.0015
98 REFLEXES ABNORMAL 1 0.0015
99 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
100 POST PROCEDURAL SEPSIS 1 0.0015
101 PARASOMNIA 1 0.0014
102 INFANTILE SPASMS 1 0.0014
103 SOMNAMBULISM 9 0.0014
104 SLEEP PARALYSIS 2 0.0014
105 NEGATIVISM 1 0.0013
106 MYOCLONIC EPILEPSY 2 0.0013
107 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
108 PLACENTA PRAEVIA 1 0.0013
109 PNEUMONIA MYCOPLASMAL 1 0.0013
110 DISINHIBITION 2 0.0012
111 SUICIDAL IDEATION 112 0.0012
112 MANIA 20 0.0012
113 SLEEP TERROR 5 0.0012
114 SEDATION COMPLICATION 3 0.0012
115 EUPHORIC MOOD 12 0.0012
116 CATATONIA 6 0.0011
117 EMOTIONAL POVERTY 2 0.0011
118 YAWNING 3 0.0011
119 CLUMSINESS 3 0.0011
120 INITIAL INSOMNIA 11 0.0011
121 NARCOLEPSY 2 0.0011
122 WRONG SCHEDULE 1 0.0010
123 CRYING 38 0.0010
124 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
125 RHINOVIRUS INFECTION 4 0.0010
126 DECREASED INTEREST 6 0.0010
127 BRADYKINESIA 6 0.0010
128 HYPERSOMNIA 29 0.0010
129 PANIC ATTACK 36 0.0010
130 HOMICIDAL IDEATION 4 0.0010
131 MATERNAL EXPOSURE DURING BREAST FEEDING 4 0.0010
132 BREAST ABSCESS 1 0.0010
133 THERAPY CESSATION 49 0.0010
134 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
135 DEREALISATION 2 0.0009
136 DYSARTHRIA 34 0.0009
137 GAIT INABILITY 30 0.0009
138 SLUGGISHNESS 9 0.0009
139 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
140 EMOTIONAL DISORDER 27 0.0009
141 NEUROLOGICAL SYMPTOM 5 0.0009
142 POLYMENORRHOEA 3 0.0009
143 HYPERVENTILATION 5 0.0009
144 COORDINATION ABNORMAL 12 0.0009
145 FEELING OF DESPAIR 4 0.0009
146 SENSE OF OPPRESSION 1 0.0008
147 CHRONIC RESPIRATORY FAILURE 1 0.0008
148 PARADOXICAL DRUG REACTION 3 0.0008
149 FACE INJURY 3 0.0008
150 INCOHERENT 5 0.0008
151 FEELINGS OF WORTHLESSNESS 1 0.0008
152 FEELING GUILTY 1 0.0008
153 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
154 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
155 DIZZINESS 369 0.0007
156 ANGER 25 0.0007
157 HYPERCALCAEMIA 9 0.0007
158 HEAD TITUBATION 1 0.0007
159 DROOLING 5 0.0007
160 ELECTRIC SHOCK SENSATION 2 0.0007
161 INTENSIVE CARE 1 0.0007
162 TEARFULNESS 3 0.0007
163 PANIC REACTION 5 0.0007
164 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
165 NEGATIVE THOUGHTS 2 0.0007
166 TREMOR 113 0.0007
167 GENERALISED ANXIETY DISORDER 1 0.0007
168 IRRITABILITY 40 0.0007
169 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
170 VIOLENCE-RELATED SYMPTOM 1 0.0006
171 NEONATAL DISORDER 1 0.0006
172 TONSILLECTOMY 1 0.0006
173 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
174 FEELING ABNORMAL 141 0.0006
175 ENTERITIS INFECTIOUS 1 0.0006
176 GAZE PALSY 1 0.0006
177 ACUTE SINUSITIS 1 0.0006
178 FEELING JITTERY 11 0.0006
179 FOOD INTERACTION 1 0.0006
180 BALANCE DISORDER 49 0.0006
181 DISORIENTATION 22 0.0006
182 BEHAVIOUR DISORDER 3 0.0006
183 NASAL OEDEMA 1 0.0006
184 PRESCRIBED UNDERDOSE 11 0.0006
185 DEPRESSED MOOD 29 0.0005
186 NONSPECIFIC REACTION 3 0.0005
187 UTERINE SPASM 1 0.0005
188 ANXIETY 155 0.0005
189 HYPOMANIA 2 0.0005
190 MEMORY IMPAIRMENT 74 0.0005
191 INTERMENSTRUAL BLEEDING 3 0.0005
192 MENTAL IMPAIRMENT 13 0.0005
193 LOSS OF CONTROL OF LEGS 2 0.0005
194 COMMUNICATION DISORDER 2 0.0005
195 PARANOIA 9 0.0005
196 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
197 DIPLEGIA 1 0.0005
198 LETHARGY 29 0.0005
199 MOOD SWINGS 16 0.0005
200 SALIVARY HYPERSECRETION 5 0.0005
201 APHASIA 15 0.0005
202 FOAMING AT MOUTH 1 0.0005
203 MUSCLE CONTRACTURE 1 0.0005
204 IMPULSE-CONTROL DISORDER 1 0.0005
205 AKINESIA 1 0.0005
206 BODY TEMPERATURE FLUCTUATION 1 0.0005
207 DEVICE CONNECTION ISSUE 1 0.0005
208 HYPERKINESIA 1 0.0005
209 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
210 ASPIRATION 5 0.0005
211 DYSGRAPHIA 3 0.0005
212 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
213 GRIP STRENGTH DECREASED 4 0.0005
214 GASTROINTESTINAL INFECTION 4 0.0004
215 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
216 BRAIN OPERATION 1 0.0004
217 PANCREATITIS NECROTISING 1 0.0004
218 IMPLANT SITE INFECTION 1 0.0004
219 ORAL SURGERY 1 0.0004
220 PRE-ECLAMPSIA 2 0.0004
221 WEIGHT ABNORMAL 1 0.0004
222 AMNESIA 27 0.0004
223 WRONG DOSE 1 0.0004
224 INTENTIONAL UNDERDOSE 3 0.0004
225 MAJOR DEPRESSION 3 0.0004
226 COGNITIVE DISORDER 19 0.0004
227 FATIGUE 314 0.0004
228 SPEECH DISORDER 21 0.0004
229 URINARY TRACT INFECTION BACTERIAL 1 0.0004
230 GAIT DISTURBANCE 75 0.0004
231 PHYSICAL DECONDITIONING 1 0.0004
232 DEPRESSION 87 0.0004
233 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
234 PERSONALITY DISORDER 1 0.0004
235 PRODUCT DOSE OMISSION ISSUE 112 0.0004
236 CONFUSIONAL STATE 61 0.0004
237 NIGHTMARE 13 0.0004
238 MIDDLE INSOMNIA 7 0.0004
239 DELIRIUM 13 0.0004
240 ALCOHOL POISONING 1 0.0004
241 PSYCHOTIC DISORDER 11 0.0004
242 FEAR 10 0.0004
243 FRUSTRATION TOLERANCE DECREASED 3 0.0004
244 DISTURBANCE IN ATTENTION 20 0.0004
245 MUSCULAR WEAKNESS 42 0.0004
246 MUSCULOSKELETAL DISORDER 7 0.0004
247 TIC 2 0.0004
248 AKATHISIA 5 0.0004
249 ASTHENOPIA 2 0.0004
250 DEAFNESS UNILATERAL 2 0.0004
251 OCULAR DISCOMFORT 4 0.0004
252 RESTLESSNESS 13 0.0004
253 VOMITING PROJECTILE 1 0.0003
254 ADENOVIRUS INFECTION 1 0.0003
255 ABORTION 1 0.0003
256 DYSSTASIA 10 0.0003
257 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
258 NECK INJURY 1 0.0003
259 ACCIDENT 4 0.0003
260 HEAVY MENSTRUAL BLEEDING 3 0.0003
261 EMERGENCY CARE 1 0.0003
262 VERTIGO 20 0.0003
263 AGITATION 24 0.0003
264 THINKING ABNORMAL 6 0.0003
265 DYSKINESIA 13 0.0003
266 SECRETION DISCHARGE 4 0.0003
267 BLEPHAROSPASM 2 0.0003
268 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
269 SENSORY DISTURBANCE 5 0.0003
270 STUPOR 1 0.0003
271 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
272 SOPOR 4 0.0003
273 POTENTIATING DRUG INTERACTION 1 0.0003
274 SUICIDE ATTEMPT 18 0.0003
275 EYE MOVEMENT DISORDER 2 0.0003
276 INSOMNIA 77 0.0003
277 PRESYNCOPE 7 0.0003
278 HYPERTRANSAMINASAEMIA 2 0.0003
279 LOGORRHOEA 1 0.0003
280 FIBRIN D DIMER INCREASED 1 0.0003
281 DEVICE PLACEMENT ISSUE 1 0.0003
282 DECREASED ACTIVITY 3 0.0003
283 ABNORMAL BEHAVIOUR 11 0.0003
284 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
285 VISUAL FIELD DEFECT 2 0.0003
286 HYPOPHAGIA 7 0.0003
287 HYPOAESTHESIA 40 0.0003
288 IMPULSIVE BEHAVIOUR 1 0.0003
289 REBOUND EFFECT 3 0.0003
290 AUTOIMMUNE THYROIDITIS 1 0.0003
291 MOBILITY DECREASED 19 0.0003
292 PARANASAL SINUS DISCOMFORT 1 0.0003
293 THYROID MASS 1 0.0003
294 DYSTONIA 5 0.0003
295 EPIGASTRIC DISCOMFORT 1 0.0003
296 ORAL INFECTION 1 0.0003
297 AFFECTIVE DISORDER 2 0.0003
298 BACTERAEMIA 3 0.0003
299 ATAXIA 3 0.0003
300 MIGRAINE 24 0.0003
301 CEREBRAL ATROPHY 1 0.0003
302 SELF-MEDICATION 1 0.0002
303 SUICIDAL BEHAVIOUR 1 0.0002
304 HALLUCINATIONS, MIXED 1 0.0002
305 HALLUCINATION, VISUAL 5 0.0002
306 ALCOHOLISM 1 0.0002
307 URINE OUTPUT DECREASED 2 0.0002
308 ONYCHOMYCOSIS 1 0.0002
309 HEAD DISCOMFORT 4 0.0002
310 THIRST 4 0.0002
311 MOOD ALTERED 6 0.0002
312 RESTLESS LEGS SYNDROME 4 0.0002
313 URINE ABNORMALITY 1 0.0002
314 AGGRESSION 11 0.0002
315 MOVEMENT DISORDER 7 0.0002
316 ABNORMAL DREAMS 6 0.0002
317 PARALYSIS 3 0.0002
318 MENTAL DISORDER 9 0.0002
319 DIZZINESS POSTURAL 2 0.0002
320 INCORRECT DOSAGE ADMINISTERED 1 0.0002
321 HYPERNATRAEMIA 1 0.0002
322 HEPATIC ENZYME ABNORMAL 1 0.0002
323 VISION BLURRED 27 0.0002
324 AMMONIA INCREASED 1 0.0002
325 PETIT MAL EPILEPSY 1 0.0002
326 INCREASED UPPER AIRWAY SECRETION 1 0.0002
327 TRISMUS 1 0.0002
328 DELUSION 3 0.0002
329 NYSTAGMUS 1 0.0002
330 JOINT INJURY 4 0.0002
331 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
332 JAW DISORDER 1 0.0002
333 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
334 HYPERKERATOSIS 1 0.0002
335 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
336 GASTRIC ULCER HAEMORRHAGE 1 0.0002
337 VIRAL INFECTION 6 0.0002
338 STREPTOCOCCAL INFECTION 1 0.0002
339 STATUS EPILEPTICUS 2 0.0002
340 DRUG INTOLERANCE 17 0.0002
341 STRESS CARDIOMYOPATHY 1 0.0002
342 ENERGY INCREASED 1 0.0002
343 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
344 TYPE 1 DIABETES MELLITUS 1 0.0002
345 UNDERDOSE 12 0.0002
346 EPILEPSY 5 0.0002
347 SCOLIOSIS 1 0.0002
348 OLIGURIA 1 0.0002
349 PNEUMONIA ASPIRATION 4 0.0002
350 HALLUCINATION 12 0.0002
351 POISONING 2 0.0002
352 LOSS OF CONSCIOUSNESS 20 0.0002
353 ILLNESS 16 0.0002
354 DIPLOPIA 4 0.0002
355 NERVOUSNESS 8 0.0002
356 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
357 LIP SWELLING 5 0.0001
358 POST-TRAUMATIC STRESS DISORDER 1 0.0001
359 SINUS CONGESTION 2 0.0001
360 FEEDING DISORDER 3 0.0001
361 RESPIRATION ABNORMAL 1 0.0001
362 ENCEPHALITIS 1 0.0001
363 FORMICATION 1 0.0001
364 HUNGER 2 0.0001
365 POOR QUALITY SLEEP 3 0.0001
366 FAECES SOFT 1 0.0001
367 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
368 SENSITIVE SKIN 1 0.0001
369 CEREBRAL DISORDER 1 0.0001
370 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
371 PARAESTHESIA 21 0.0001
372 COMPLETED SUICIDE 11 0.0001
373 OSTEOPENIA 2 0.0001
374 TREATMENT NONCOMPLIANCE 7 0.0001
375 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
376 PNEUMOTHORAX 2 0.0001
377 TRICUSPID VALVE INCOMPETENCE 1 0.0001
378 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
379 SENSORY LOSS 1 0.0001
380 SUBSTANCE ABUSE 1 0.0001
381 GASTROINTESTINAL DISORDER 11 0.0001
382 DRUG INEFFECTIVE 161 0.0001
383 MENSTRUAL DISORDER 1 0.0001
384 LIVE BIRTH 1 0.0001
385 SENSATION OF FOREIGN BODY 1 0.0001
386 CANDIDA INFECTION 2 0.0001
387 FACIAL PARALYSIS 1 0.0001
388 CHEST DISCOMFORT 12 0.0001
389 ASTHENIA 44 0.0001
390 UNRESPONSIVE TO STIMULI 3 0.0001
391 PSYCHOLOGICAL TRAUMA 1 0.0001
392 DISCOMFORT 7 0.0001
393 BLOOD CALCIUM INCREASED 1 0.0001
394 MENSTRUATION IRREGULAR 3 0.0001
395 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
396 HAEMOLYTIC ANAEMIA 1 0.0001
397 URINARY TRACT INFECTION 19 0.0001
398 THERAPY NON-RESPONDER 5 0.0001
399 FREQUENT BOWEL MOVEMENTS 3 0.0001
400 HEART RATE INCREASED 11 0.0001
401 GASTROENTERITIS VIRAL 2 0.0001
402 MUSCLE SPASMS 20 0.0001
403 NAUSEA 86 0.0001
404 FLANK PAIN 1 0.0001
405 PHOTOPHOBIA 2 0.0001
406 ABORTION INDUCED 1 0.0001
407 INTENTIONAL DOSE OMISSION 3 0.0001
408 AFFECT LABILITY 1 0.0001
409 EAR PAIN 2 0.0001
410 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
411 VOMITING 48 0.0001
412 HEPATOMEGALY 1 0.0001
413 BODY TEMPERATURE DECREASED 1 0.0001
414 COMPLICATION OF DEVICE INSERTION 2 0.0001
415 RESPIRATORY DISORDER 3 0.0001
416 HYPOTONIA 1 0.0001
417 INTENTIONAL SELF-INJURY 2 0.0001
418 PRODUCT ADMINISTRATION ERROR 2 0.0001
419 HYPOTHERMIA 1 0.0001
420 DRY THROAT 1 0.0001
421 THERAPY INTERRUPTED 7 0.0001
422 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
423 HELICOBACTER INFECTION 1 0.0001
424 HEADACHE 61 0.0001
425 TEMPERATURE INTOLERANCE 1 0.0001
426 VISUAL IMPAIRMENT 12 0.0001
427 PNEUMONIA 31 0.0001
428 DRUG-INDUCED LIVER INJURY 3 0.0001
429 WITHDRAWAL SYNDROME 4 0.0001
430 BREAST PAIN 1 0.0001
431 IRRITABLE BOWEL SYNDROME 2 0.0001
432 HYPOACUSIS 4 0.0001
433 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
434 RASH PRURITIC 5 0.0001
435 FAECES DISCOLOURED 2 0.0001
436 SKIN LACERATION 1 0.0001
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
438 DENTAL CARIES 1 0.0001
439 SYNCOPE 9 0.0001
440 NERVE INJURY 1 0.0001
441 IMPAIRED DRIVING ABILITY 1 0.0001
442 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
443 HEART RATE DECREASED 3 0.0001
444 HYPERHIDROSIS 11 0.0001
445 SLEEP DISORDER 6 0.0001
446 FALL 28 0.0001
447 MYOCLONUS 1 0.0001
448 MUSCLE RIGIDITY 1 0.0001
449 BLOOD PRESSURE FLUCTUATION 2 0.0001
450 ADRENAL INSUFFICIENCY 1 0.0001
451 HOT FLUSH 6 0.0001
452 HAEMATEMESIS 2 0.0001
453 MYDRIASIS 1 0.0001
454 RESPIRATORY TRACT INFECTION 2 0.0001
455 BEDRIDDEN 1 0.0001
456 DIARRHOEA 49 0.0001
457 DYSMENORRHOEA 1 0.0001
458 ADVERSE REACTION 1 0.0001
459 EAR INFECTION 2 0.0001
460 IMPAIRED GASTRIC EMPTYING 1 0.0001
461 HAEMATOCHEZIA 4 0.0001
462 MENTAL STATUS CHANGES 2 0.0001
463 FEELING COLD 2 0.0001
464 HYPOMAGNESAEMIA 1 0.0001
465 INFLUENZA 8 0.0001
466 APHONIA 1 0.0001
467 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
468 SINUS TACHYCARDIA 1 0.0001
469 PARAESTHESIA ORAL 1 0.0001
470 HYPOKINESIA 1 0.0001
471 APATHY 1 0.0001
472 GASTROENTERITIS 1 0.0001
473 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
474 HYPOAESTHESIA ORAL 1 0.0001
475 ABDOMINAL DISCOMFORT 11 0.0001
476 ANKLE FRACTURE 1 0.0001
477 DECREASED APPETITE 15 0.0001
478 CYANOSIS 1 0.0001
479 PRODUCT USE COMPLAINT 1 0.0001
480 COMA 3 0.0001
481 HALLUCINATION, AUDITORY 1 0.0001
482 ABSCESS 1 0.0001
483 DRUG LEVEL INCREASED 1 0.0001
484 CHILLS 7 0.0001
485 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
486 BLOOD PRESSURE INCREASED 9 0.0001
487 HOSPITALISATION 9 0.0001
488 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
489 WEIGHT INCREASED 13 0.0001
490 DEVICE USE ISSUE 1 0.0001
491 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
492 DRUG WITHDRAWAL SYNDROME 5 0.0001
493 HYPOXIA 2 0.0001
494 COLD SWEAT 1 0.0001
495 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
496 ADVERSE DRUG REACTION 5 0.0001
497 LEUKOCYTOSIS 1 0.0001
498 NASOPHARYNGITIS 10 0.0001
499 WEIGHT DECREASED 15 0.0001
500 HEPATIC STEATOSIS 1 0.0001
501 OFF LABEL USE 47 0.0001
502 ABDOMINAL PAIN UPPER 11 0.0001
503 FLATULENCE 3 0.0001
504 INCREASED APPETITE 1 0.0001
505 SEROTONIN SYNDROME 1 0.0001
506 LOWER LIMB FRACTURE 1 0.0001
507 CHOKING 1 0.0001
508 ORAL HERPES 1 0.0001
509 KIDNEY INFECTION 1 0.0001
510 ALOPECIA 10 0.0001
511 DYSPEPSIA 5 0.0001
512 DRUG INTERACTION 8 0.0001
513 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
514 ABORTION SPONTANEOUS 2 0.0000
515 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
516 DRY MOUTH 4 0.0000
517 BODY TEMPERATURE INCREASED 1 0.0000
518 FEELING HOT 3 0.0000
519 CHEST PAIN 9 0.0000
520 EXPOSURE DURING PREGNANCY 3 0.0000
521 CARDIO-RESPIRATORY ARREST 2 0.0000
522 EATING DISORDER 1 0.0000
523 IMPAIRED WORK ABILITY 1 0.0000
524 INTENTIONAL OVERDOSE 3 0.0000
525 VAGINAL HAEMORRHAGE 2 0.0000
526 PRODUCT PRESCRIBING ISSUE 1 0.0000
527 CONSTIPATION 10 0.0000
528 PRODUCT STORAGE ERROR 4 0.0000
529 MELAENA 1 0.0000
530 SEPSIS 5 0.0000
531 RASH PAPULAR 1 0.0000
532 SNEEZING 1 0.0000
533 THROAT IRRITATION 2 0.0000
534 CHROMATURIA 1 0.0000
535 TINNITUS 2 0.0000
536 PYREXIA 15 0.0000
537 PALPITATIONS 5 0.0000
538 PRODUCT PRESCRIBING ERROR 1 0.0000
539 EMOTIONAL DISTRESS 5 0.0000
540 NEURALGIA 1 0.0000
541 MALAISE 18 0.0000
542 ENCEPHALOPATHY 1 0.0000
543 DYSGEUSIA 3 0.0000
544 EXTRAPYRAMIDAL DISORDER 1 0.0000
545 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
546 DRY EYE 2 0.0000
547 HEPATITIS 1 0.0000
548 GASTRITIS 1 0.0000
549 DEHYDRATION 5 0.0000
550 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
551 PAIN OF SKIN 1 0.0000
552 OVERDOSE 8 0.0000
553 THROAT TIGHTNESS 1 0.0000
554 INFLUENZA LIKE ILLNESS 3 0.0000
555 RESPIRATORY ARREST 1 0.0000
556 RESPIRATORY DISTRESS 1 0.0000
557 TREATMENT FAILURE 3 0.0000
558 ANAPHYLACTIC REACTION 2 0.0000
559 BLISTER 2 0.0000
560 OXYGEN SATURATION DECREASED 2 0.0000
561 EYE PAIN 2 0.0000
562 ASTHMA 4 0.0000
563 EYE IRRITATION 2 0.0000
564 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
565 INFECTION 5 0.0000
566 COVID-19 6 0.0000
567 SURGERY 2 0.0000
568 TACHYCARDIA 3 0.0000
569 URINARY INCONTINENCE 1 0.0000
570 BLOOD POTASSIUM DECREASED 1 0.0000
571 LACRIMATION INCREASED 1 0.0000
572 THERAPEUTIC RESPONSE DECREASED 2 0.0000
573 CONDITION AGGRAVATED 10 0.0000
574 ADVERSE EVENT 3 0.0000
575 LIMB DISCOMFORT 1 0.0000
576 FEMUR FRACTURE 1 0.0000
577 RASH 14 0.0000
578 NERVOUS SYSTEM DISORDER 1 0.0000
579 DYSPHAGIA 3 0.0000
580 HEAD INJURY 1 0.0000
581 METABOLIC ACIDOSIS 1 0.0000
582 NIGHT SWEATS 1 0.0000
583 RHINORRHOEA 2 0.0000
584 EYE DISORDER 1 0.0000
585 VISUAL ACUITY REDUCED 1 0.0000
586 FUNGAL INFECTION 1 0.0000
587 SKIN DISORDER 1 0.0000
588 URINARY RETENTION 1 0.0000
589 URTICARIA 5 0.0000
590 HAEMATURIA 1 0.0000
591 HAEMORRHAGE 3 0.0000
592 BURNING SENSATION 2 0.0000
593 HYPERKALAEMIA 1 0.0000
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
595 SKIN BURNING SENSATION 2 0.0000
596 HYPERGLYCAEMIA 1 0.0000
597 RESPIRATORY FAILURE 2 0.0000
598 PAIN IN EXTREMITY 8 0.0000
599 HYPERSENSITIVITY 5 0.0000
600 HEPATIC FUNCTION ABNORMAL 1 0.0000
601 INTESTINAL OBSTRUCTION 1 0.0000
602 ACNE 2 0.0000
603 PAIN 16 0.0000
604 OSTEOPOROSIS 1 0.0000
605 CARDIAC ARREST 2 0.0000
606 POLLAKIURIA 1 0.0000
607 ROAD TRAFFIC ACCIDENT 1 0.0000
608 HYPERTENSION 5 0.0000
609 MYALGIA 4 0.0000
610 PRURITUS 9 0.0000
611 INTENTIONAL PRODUCT MISUSE 2 0.0000
612 MUSCULOSKELETAL STIFFNESS 2 0.0000
613 LIVER DISORDER 1 0.0000
614 INCORRECT DOSE ADMINISTERED 5 0.0000
615 NEPHROLITHIASIS 1 0.0000
616 SKIN DISCOLOURATION 1 0.0000
617 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
618 OROPHARYNGEAL PAIN 2 0.0000
619 BACK PAIN 5 0.0000
620 ABDOMINAL PAIN 5 0.0000
621 ARRHYTHMIA 1 0.0000
622 RASH ERYTHEMATOUS 1 0.0000
623 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
624 ACUTE KIDNEY INJURY 3 0.0000
625 PERIPHERAL SWELLING 3 0.0000
626 ECZEMA 1 0.0000
627 PANCREATITIS 1 0.0000
628 BRADYCARDIA 1 0.0000
629 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
630 PLATELET COUNT DECREASED 2 0.0000
631 MEDICATION ERROR 1 0.0000
632 DYSPHONIA 1 0.0000
633 NASAL CONGESTION 1 0.0000
634 JOINT SWELLING 2 0.0000
635 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
636 PRODUCT USE ISSUE 3 0.0000
637 ANAEMIA 3 0.0000
638 HEPATIC ENZYME INCREASED 1 0.0000
639 ARTHRALGIA 6 0.0000
640 COUGH 4 0.0000
641 INJURY 1 0.0000
642 DEATH 12 0.0000
643 BRONCHITIS 1 0.0000
644 EPISTAXIS 1 0.0000
645 UNEVALUABLE EVENT 1 0.0000
646 ARTHRITIS 1 0.0000
647 CARDIAC FAILURE 1 0.0000
648 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
649 RENAL IMPAIRMENT 1 0.0000
650 TOXICITY TO VARIOUS AGENTS 2 0.0000
651 SWELLING 1 0.0000
652 DYSPNOEA 6 0.0000
653 HYPOTENSION 2 0.0000
654 FLUSHING 1 0.0000
655 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
656 SINUSITIS 1 0.0000
657 HAEMOGLOBIN DECREASED 1 0.0000
658 ABDOMINAL DISTENSION 1 0.0000
659 OEDEMA PERIPHERAL 1 0.0000
660 PSORIASIS 1 0.0000
661 PRODUCT QUALITY ISSUE 1 0.0000
662 INJECTION SITE PAIN 2 0.0000
663 CEREBROVASCULAR ACCIDENT 1 0.0000
664 MYOCARDIAL INFARCTION 1 0.0000
665 NO ADVERSE EVENT 1 0.0000
666 ERYTHEMA 1 0.0000